Enterprise record

Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:5f0c9441-208c-4071-842f-a6b8a4349343Version: public-1As of: unavailable

8 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 29, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 29, 2026

    Supports 3 claims
    • Legal Name: Sonoma Pharmaceuticals, Inc. · Claim reviewed: Sep 29, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 29, 2026
    • Published Fact: US · Claim reviewed: Sep 29, 2026

  2. Sonoma Pharmaceuticals, Inc. DEF 14A 2025-07-11

    sec proxy · Source published: Jul 11, 2025 · Retrieved: Apr 28, 2026

    Supports 4 claims
    • Leadership Role: Amy Trombly: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jay Birnbaum: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jerry McLaughlin: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Philippe Weigerstorfer: Director · Claim reviewed: Sep 29, 2026

  3. SNOA DEF 14A executive officers

    sec filing · Source published: May 5, 2026 · Retrieved: May 16, 2026

    Supports 1 claim
    • Leadership Role: Julia Amrock: Vice President, Associate General Counsel and Corporate Secretary · Claim reviewed: Sep 29, 2026